New research published in The Lancet has examined the gender-differential effects of the doses of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) and β blockers when used for heart failure with reduced ejection fraction (HFrEF)....
The link between the AKR1D1*36 (rs1872930) allele and risk of major adverse cardiovascular and cerebrovascular events (MACCE) in patients taking clopidogrel has been examined in a recent observational pharmacogenomic cohort study. 118 patients (median age 62.5 years)...
An evaluation of a 12-month pilot service involving referral of patients to specialist mental health pharmacist independent prescribers has recently been completed in Scotland. 75 patients from 2 rural and remote general practices were included in the study, which...
The increasing incidence of Alzheimer’s disease has seen an accompanying increase in adverse drug events (ADEs) related to various psychotropic medications used by these patients. To assess the prevalence and economic burden of psychotropic ADEs, American...
The effectiveness of paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) in acute musculoskeletal trauma has been compared in a multi-centre, double-blind, randomised clinical trial conducted in the Netherlands. 547 adults with acute blunt minor...
